Sigyn Therapeutics
View On Demand

Fighting COVID-19 With Blood Purification Technology

About the Event


In April of 2020, the FDA published a statement that blood purification devices may be effective at treating certain patients with confirmed COVID-19 by reducing various pathogens, cytokines, and other inflammatory mediators from the bloodstream.

Sigyn Therapeutics [OTC:SIGY] has reported results from a series of in vitro blood purification studies that have validated the ability of Sigyn Therapy to extract viral pathogens including COVID-19 from human blood plasma. Pre-infection preventives like the mRNA vaccines are important, but as additional variants are discovered and people experience breakthrough infections, blood purification technology like Sigyn Therapy could be used to save millions of lives.

Please join our webinar with Sigyn CEO, Jim Joyce. He’ll discuss how a properly designed blood purification device can perform functions that are beyond the reach of drugs and have broad applications for the treatment of pandemic viruses and beyond.

View On-Demand Webinar


SHARE THIS EVENT
Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.